Action PLRX PLIANT THERAPEUTICS, INC.
Ajouter à une liste
Pour utiliser cette fonction vous devez être client ou membre
ConnexionInscription

Autres langues Pliant Therapeutics, Inc.

Actions

PLRX

US7291391057

Marché Fermé - Nasdaq
Autres places de cotation
 22:00:00 12/06/2024 		Varia. 5j. Varia. 1 janv.
11,76 USD +4,16 % Graphique intraday de Pliant Therapeutics, Inc. -2,81 % -35,06 %
14/05 Mise à jour sectorielle : Les actions du secteur de la santé ralentissent dans l'après-midi de mardi MT
14/05 Pliant Therapeutics rapporte des données de base positives dans un essai sur la fibrose pulmonaire idiopathique MT

Autres langues

Recherche
Voir les résultats
Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !
Inscription 100% Gratuite
Pliant Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Pliant Therapeutics Presents Data from its Bexotegrast Program at the European Association for the Study of the Liver (EASL) International Liver Congress™
Pliant Therapeutics Presents Data from its Bexotegrast Program at the American Thoracic Society International Conference
Sector Update: Health Care Stocks Ease in Tuesday Afternoon Trading
Pliant Therapeutics Reports Positive Topline Data in Idiopathic Pulmonary Fibrosis Trial
Pliant Therapeutics : Phase 2a PET Imaging Trial
Pliant Therapeutics Announces Positive Topline Data from a Phase 2a Collagen PET Imaging Clinical Trial of Bexotegrast in Patients with Idiopathic Pulmonary Fibrosis
Pliant Therapeutics Announces Positive Topline Data from a Phase 2a Collagen PET Imaging Clinical Trial of Bexotegrast in Patients with Idiopathic Pulmonary Fibrosis
Pliant Therapeutics, Inc. Announces Positive Topline Data from A Phase 2A Collagen Pet Imaging Clinical Trial of Bexotegrast in Patients with Idiopathic Pulmonary Fibrosis
Pliant Therapeutics Announces Upcoming Presentations at the European Association for the Study of the Liver International Liver Congress™
Pliant Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024
Pliant Therapeutics Provides Corporate Update and Reports First Quarter 2024 Financial Results
Pliant Therapeutics Provides Corporate Update and Reports First Quarter 2024 Financial Results
Pliant Therapeutics to Participate in Upcoming Investor Events
Pliant Therapeutics to Participate in Upcoming Investor Events
Pliant Therapeutics to Participate in Upcoming Investor Events
Pliant Therapeutics Announces Upcoming Presentations at the 2024 American Thoracic Society International Conference
Nimbus Therapeutics Appoints Katharine Knobil, M.D., to Board of Directors
Pliant Therapeutics, Inc. Announces Accelerated Bexotegrast Development Plan for the Treatment of Idiopathic Pulmonary Fibrosis
Pliant Therapeutics Announces Accelerated Bexotegrast Development Plan for the Treatment of Idiopathic Pulmonary Fibrosis
Aucun résultat pour cette recherche
Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Filtres

Rechercher

Date de publication

Depuis le

Jusqu'au

  1. Bourse
  2. Actions
  3. Action PLRX
  4. Actualités Pliant Therapeutics, Inc.
  5. Autres langues